Physical Therapists in Boardman, OH Accepting Medicare

58 Physical Therapists found. Showing 21 - 40

Mr. Ronald William Wolford, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 45 Mcclurg Rd, Boardman, OH 44512 Phone: 330-729-1440    Fax: 330-729-1530

Elizabeth Ann Hritz, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1265 Boardman Canfield Rd, Boardman, OH 44512 Phone: 330-758-9400    Fax: 330-726-8676

Kyle Banna, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1265 Boardman Canfield Rd, Boardman, OH 44512 Phone: 330-758-9400    Fax: 330-726-8676

Zachary John Collins, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 813 Boardman Poland Rd Ste 12b, Boardman, OH 44512 Phone: 330-729-9448    Fax: 234-226-4216

Kristy L Gentile, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8064 South Ave, Boardman, OH 44512 Phone: 330-726-3700

Mrs. Mary Ali, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 8064 South Ave, Boardman, OH 44512 Phone: 330-726-3700    Fax: 330-965-1858

Southwoods Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7620 Southern Blvd, Suite 3, Boardman, OH 44512 Phone: 330-965-9330    Fax: 330-965-9311

Miss Maggie P Glaros, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1265 Boardman Canfield Rd, Boardman, OH 44512 Phone: 330-758-9400    Fax: 330-726-8676

Mr. Michael V Farris, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 835 Mckay Ct Ste 100, Boardman, OH 44512 Phone: 330-965-3899    Fax: 330-965-3839

Daniel Shobel Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1265 Boardman Canfield Rd, Boardman, OH 44512 Phone: 330-758-9400    Fax: 330-726-8676

Lindsay Marie Lorenzo, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1265 Boardman Canfield Rd, Boardman, OH 44512 Phone: 330-758-9400    Fax: 330-726-8676

Aaron Dunlany Physical Therapist Medicare: Medicare Enrolled Practice Location: 813 Boardman Poland Rd Ste 12b, Boardman, OH 44512 Phone: 330-729-9448    Fax: 234-226-4216

Michael John Sturgiss, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 835 Mckay Ct Ste 100, Boardman, OH 44512 Phone: 330-965-3899    Fax: 330-965-3839

Theodore Lenton, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 7620 Southern Blvd, Suite 3, Boardman, OH 44512 Phone: 330-965-9330    Fax: 330-965-9308

Stephanie S Porter, L.P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1265 Boardman Canfield Rd, Boardman, OH 44512 Phone: 330-758-9400    Fax: 330-726-8676

Kristy L Ebinger, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 7620 Southern Blvd, Suite 3, Boardman, OH 44512 Phone: 330-965-9330    Fax: 330-965-9308

Soriya Rezapourian, PT, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 8561 Market St, Boardman, OH 44512 Phone: 330-953-2383

Sandra M Ciccone, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 721 Boardman Poland Rd, Boardman, OH 44512 Phone: 330-726-9671

Lifeline Partners, Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 250 Debartolo Pl, Suite 1535, Boardman, OH 44512 Phone: 330-759-5981    Fax: 330-759-9677

Joshua Hoppe, DPT, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 7000 South Ave Ste 7, Boardman, OH 44512 Phone: 330-629-8834

News Archive

SRI and Taiho collaborate to advance clinical development of TAS-108 breast cancer program

SRI International, an independent nonprofit research and development organization, announced today that it has assumed responsibility for further clinical development of the TAS-108 breast cancer program, in cooperation with Taiho Pharmaceuticals Co., Ltd., a leading Japanese pharmaceutical company. Further clinical development will focus on the lead compound's registration for the treatment of tamoxifen and aromatase inhibitor-resistant breast cancers.

IQWiG tests suitability of AHP method for identifying preferences of patients regarding treatment goals

It is more important to patients suffering from depression that they show a noticeable response to treatment in the first place than being completely cured. It is exactly the opposite in physicians treating people with this disease: they consider remission to have higher priority than response.

Lipid profile differences explain why two people with the same overall cholesterol level can have different degrees of cardiovascular disease

When it comes to lipid profiles - a key measure of heart disease risk- it appears that African-Americans and women have it better than whites and men, according to a new study by Duke University Medical Center researchers.

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Micell Technologies,™ Inc. today announced it has enrolled the first patient in the DESSOLVE II (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries) clinical trial. Stefan Verheye, M.D., Ph.D. at Middelheim Hospital, Antwerp, Belgium enrolled the first patient in the study. This clinical investigation is being conducted to support CE Mark approval of the company's MiStent™ Drug-Eluting Coronary Stent System (MiStent DES).

Durata attains global rights for dalbavancin to treat abSSSI

Durata Therapeutics today announced the Company has attained worldwide rights for the development and commercialization of Durata's lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). In December 2010, Durata acquired from RaQualia Pharma commercialization rights for dalbavancin in Japan.

Read more Medical News

› Verified 4 days ago

• 1
• 2(current)
• 3